Form 4: Sabra Health Care REIT Director Acquires Shares Through Dividend Equivalent Payments
SEC Form 4 Filing
Director Catherine Cusack acquired 727 shares of Sabra Health Care REIT through dividend equivalent payments, increasing her total holdings to 58,083 shares.
Summary
- Catherine Cusack, a director at Sabra Health Care REIT, acquired 727 shares of common stock on November 29, 2024.
- These shares were acquired through dividend equivalent payments on previously granted stock units.
- The acquisition did not involve a direct purchase, with the price per share listed as $0.
- Following the transaction, Ms. Cusack's total holdings increased to 58,083 shares.
- This total includes 5,718 unvested stock units and 40,365 vested stock units with deferred payment.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects a routine transaction that aligns director interests with shareholders. There are no negative implications.
Positives
- The acquisition of shares through dividend equivalents indicates a continued alignment of director interests with shareholder value.
- The increase in share ownership by a director can be seen as a positive sign of confidence in the company's future.
Industry Context
This filing is a routine disclosure of insider transactions, which is common in the REIT sector. It reflects the ongoing compensation and ownership structure within Sabra Health Care REIT.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies, including REITs like Sabra Health Care REIT.
- The use of stock units and dividend equivalents is a common method of compensation for directors and executives in the industry.
- Comparable companies such as Welltower (WELL) and Ventas (VTR) also have similar insider transaction disclosures.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it demonstrates director alignment with company performance.
- The transaction has no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 11/29/2024 | Date of the transaction where Catherine Cusack acquired shares through dividend equivalent payments. |
| 12/03/2024 | Date the Form 4 was signed by Michael Costa, as Attorney-in-Fact. |
Keywords
Sabra Health Care REIT, Director Shareholding, Dividend Equivalent, Stock Units, Form 4, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.